Cargando…

Liver cirrhosis leads to poorer survival in patients with end-stage renal disease

BACKGROUND/AIMS: Liver cirrhosis (LC) is an important problem in patients withend-stage renal disease (ESRD). Few studies have investigated the inf luence ofLC on mortality in patients with ESRD. This study investigated the associationbetween LC and mortality among patients with ESRD and compare mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ae Jin, Lim, Hye Jin, Ro, Han, Jung, Ji Yong, Lee, Hyun Hee, Chung, Wookyung, Chang, Jae Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939491/
https://www.ncbi.nlm.nih.gov/pubmed/27017394
http://dx.doi.org/10.3904/kjim.2014.328
_version_ 1782442009495076864
author Kim, Ae Jin
Lim, Hye Jin
Ro, Han
Jung, Ji Yong
Lee, Hyun Hee
Chung, Wookyung
Chang, Jae Hyun
author_facet Kim, Ae Jin
Lim, Hye Jin
Ro, Han
Jung, Ji Yong
Lee, Hyun Hee
Chung, Wookyung
Chang, Jae Hyun
author_sort Kim, Ae Jin
collection PubMed
description BACKGROUND/AIMS: Liver cirrhosis (LC) is an important problem in patients withend-stage renal disease (ESRD). Few studies have investigated the inf luence ofLC on mortality in patients with ESRD. This study investigated the associationbetween LC and mortality among patients with ESRD and compare mortality betweentwo dialysis modalities. METHODS: Adult patients (≥ 18 years of age) starting dialysis for ESRD were enrolledin the present study from 2000 to 2011. We analyzed 1,069 patients withESRD; of these, 742 patients were undergoing hemodialysis (HD) and 327 patientswere undergoing peritoneal dialysis (PD). RESULTS: The prevalence of LC was 44 of 1,069 patients (4.1%). The cumulative 1-,3-, and 5-year survival rates of noncirrhotic patients were 93%, 83%, and 73%, respectively,whereas the equivalent survival rates of cirrhotic patients were 90%,68%, and 48%, respectively (p = 0.011). After adjustment, LC was an independentrisk factor for death in patients with ESRD. No difference in mortality associatedwith LC was found between the HD and PD subgroups. CONCLUSIONS: Of the patients with ESRD, cirrhotic patients had poorer survivalthan noncirrhotic patients. Among patients with ESRD and LC, survival of patientsundergoing PD may be comparable with that of patients undergoing HD.
format Online
Article
Text
id pubmed-4939491
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-49394912016-07-11 Liver cirrhosis leads to poorer survival in patients with end-stage renal disease Kim, Ae Jin Lim, Hye Jin Ro, Han Jung, Ji Yong Lee, Hyun Hee Chung, Wookyung Chang, Jae Hyun Korean J Intern Med Original Article BACKGROUND/AIMS: Liver cirrhosis (LC) is an important problem in patients withend-stage renal disease (ESRD). Few studies have investigated the inf luence ofLC on mortality in patients with ESRD. This study investigated the associationbetween LC and mortality among patients with ESRD and compare mortality betweentwo dialysis modalities. METHODS: Adult patients (≥ 18 years of age) starting dialysis for ESRD were enrolledin the present study from 2000 to 2011. We analyzed 1,069 patients withESRD; of these, 742 patients were undergoing hemodialysis (HD) and 327 patientswere undergoing peritoneal dialysis (PD). RESULTS: The prevalence of LC was 44 of 1,069 patients (4.1%). The cumulative 1-,3-, and 5-year survival rates of noncirrhotic patients were 93%, 83%, and 73%, respectively,whereas the equivalent survival rates of cirrhotic patients were 90%,68%, and 48%, respectively (p = 0.011). After adjustment, LC was an independentrisk factor for death in patients with ESRD. No difference in mortality associatedwith LC was found between the HD and PD subgroups. CONCLUSIONS: Of the patients with ESRD, cirrhotic patients had poorer survivalthan noncirrhotic patients. Among patients with ESRD and LC, survival of patientsundergoing PD may be comparable with that of patients undergoing HD. The Korean Association of Internal Medicine 2016-07 2016-03-26 /pmc/articles/PMC4939491/ /pubmed/27017394 http://dx.doi.org/10.3904/kjim.2014.328 Text en Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Ae Jin
Lim, Hye Jin
Ro, Han
Jung, Ji Yong
Lee, Hyun Hee
Chung, Wookyung
Chang, Jae Hyun
Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
title Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
title_full Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
title_fullStr Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
title_full_unstemmed Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
title_short Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
title_sort liver cirrhosis leads to poorer survival in patients with end-stage renal disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939491/
https://www.ncbi.nlm.nih.gov/pubmed/27017394
http://dx.doi.org/10.3904/kjim.2014.328
work_keys_str_mv AT kimaejin livercirrhosisleadstopoorersurvivalinpatientswithendstagerenaldisease
AT limhyejin livercirrhosisleadstopoorersurvivalinpatientswithendstagerenaldisease
AT rohan livercirrhosisleadstopoorersurvivalinpatientswithendstagerenaldisease
AT jungjiyong livercirrhosisleadstopoorersurvivalinpatientswithendstagerenaldisease
AT leehyunhee livercirrhosisleadstopoorersurvivalinpatientswithendstagerenaldisease
AT chungwookyung livercirrhosisleadstopoorersurvivalinpatientswithendstagerenaldisease
AT changjaehyun livercirrhosisleadstopoorersurvivalinpatientswithendstagerenaldisease